Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT04007601

Neurostimulation In Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL)

Conditions: Acute Lymphoblastic Leukemia

Sex: All
Ages: 18 Years – 39 Years
Healthy volunteers: No
Phase: NA
Enrollment: 127
Sponsor: St. Jude Children's Research Hospital

Location: St. Jude Children's Research Hospital Memphis Tennessee

Summary

Long-term survivors of ALL are at-risk for neurocognitive impairment, particularly in the area of executive functioning. Relatively limited research has focused on interventions for improving neurocognitive outcomes in long-term survivors of ALL. A promising technique for cognitive enhancement is Transcranial Direct Current Stimulation (tDCS) which differs from conventional cognitive remediation approaches in that it directly stimulates specific brain regions responsible for cognitive processes and activates functional networks similar to those activated during cognitive training. Primary Objective To evaluate the efficacy of home-based transcranial direct current stimulation (tDCS) paired with remote cognitive training on direct testing of executive function in survivors of ALL. Secondary Objectives * To evaluate the efficacy of home-based transcranial direct current stimulation (tDCS) paired with remote cognitive training on patient-reported symptoms of executive dysfunction in survivors of ALL. * To examine the effects of home-based tDCS paired with remote cognitive training on patterns of regional brain activation as measured by functional magnetic resonance imaging. * To examine the effects of home-based tDCS paired with remote cognitive training on white matter integrity and structure as measured by diffusion tensor imaging.

Eligibility Criteria

Inclusion Criteria: * Completed treatment for acute lymphoblastic leukemia (ALL) at SJCRH \< 21 years at diagnosis * Enrolled on St. Jude Lifetime Cohort Study * ≥ 5 years post-diagnosis of ALL * ≥ 2 years post-treatment completion deemed to impact the central nervous system. * Currently between 18 and 39 years of age * English language proficiency * Executive dysfunction defined as having an age-adjusted standard score \84th percentile on the Childhood Cancer Survivor Study Neurocognitive Questionnaire or the Behavior Rating Scale of Executive Function Exclusion Criteria: * Full scale intelligence score \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04007601). StuddyBuddy aggregates publicly available trial information.